Lantern Pharma Inc. (LTRN) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
9/25
Growth 3
Margin 2
Expansion 3
Platform 1
Financial 0
latest quarter score
Earnings Reports
- 9
- 10
- 22
- 11
- 11